Literature DB >> 19758691

A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer.

O Zivanovic1, J Carter, N D Kauff, Richard R Barakat.   

Abstract

OBJECTIVE: The standard management for women diagnosed with endometrial carcinoma (EC) is hysterectomy with salpingo-oophorectomy. However, more conservative treatment approaches, including uterine and ovarian preservation, may be used for women who have a strong desire to maintain fertility in spite of potential oncologic risks.
METHODS: We reviewed the literature regarding fertility-preserving treatment for EC. We also conducted medical chart reviews for two young patients diagnosed with EC whose treatment deviated from the standard approach in order to preserve fertility. These patients were subsequently diagnosed with ovarian cancer. Our review summarizes the literature regarding the clinical and emotional implications of fertility preservation in young women. CASES: Two young nulliparous women (29 and 23 years, respectively) with grade 1 endometrioid adenocarcinoma were initially treated with conservative fertility-sparing endocrine therapy. Upon failure of endocrine treatment both women underwent hysterectomy and staging with ovarian preservation. During surveillance, both women were subsequently diagnosed with ovarian carcinoma and underwent bilateral salpingo-oophorectomy (BSO) and comprehensive staging.
CONCLUSION: The management of young women with endometrial cancer can be complex and challenging. Patients and physicians are confronted with the dilemma of following standard surgical guidelines versus the desire to maintain fertility and avoid surgical menopause. Careful oncologic, psychotherapeutic, genetic and reproductive counseling is advised before offering a non-standard treatment strategy to young endometrial cancer patients.

Entities:  

Mesh:

Year:  2009        PMID: 19758691     DOI: 10.1016/j.ygyno.2009.08.011

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  13 in total

1.  Asian society of gynecologic oncology workshop 2010.

Authors:  Dong Hoon Suh; Jae Weon Kim; Mohamad Farid Aziz; Uma K Devi; Hextan Y S Ngan; Joo-Hyun Nam; Seung Cheol Kim; Tomoyasu Kato; Hee Sug Ryu; Shingo Fujii; Yoon Soon Lee; Jong Hyeok Kim; Tae-Joong Kim; Young Tae Kim; Kung-Liahng Wang; Taek Sang Lee; Kimio Ushijima; Sang-Goo Shin; Yin Nin Chia; Sarikapan Wilailak; Sang Yoon Park; Hidetaka Katabuchi; Toshiharu Kamura; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.

Authors:  Omar Habeeb; Lee Goodglick; Robert A Soslow; Rajiv G Rao; Lynn K Gordon; Osvaldo Schirripa; Steve Horvath; Jonathan Braun; David B Seligson; Madhuri Wadehra
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

Review 3.  Fertility preserving options in patients with gynecologic malignancies.

Authors:  Ramez N Eskander; Leslie M Randall; Michael L Berman; Krishnansu S Tewari; Philip J Disaia; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2011-03-16       Impact factor: 8.661

4.  Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma.

Authors:  Hiroyuki Fujiwara; Toshiko Jobo; Yuji Takei; Yasushi Saga; Manami Imai; Tsutomu Arai; Akiyo Taneichi; Shizuo Machida; Yoshifumi Takahashi; Mitsuaki Suzuki
Journal:  Oncol Lett       Date:  2012-02-10       Impact factor: 2.967

5.  Characteristics and prognosis of coexisting adnexa malignancy with endometrial cancer: a single institution review of 51 cases.

Authors:  Lu Chen; Qiang Zhao; Xiaojuan Lv
Journal:  Arch Gynecol Obstet       Date:  2010-06-29       Impact factor: 2.344

Review 6.  Fertility-preservation in endometrial cancer: is it safe? Review of the literature.

Authors:  Márcia Mendonça Carneiro; Rívia Mara Lamaita; Márcia Cristina França Ferreira; Agnaldo Lopes Silva-Filho
Journal:  JBRA Assist Reprod       Date:  2016-12-01

7.  Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation.

Authors:  A N Schüring; T Fehm; K Behringer; M Goeckenjan; P Wimberger; M Henes; J Henes; M F Fey; M von Wolff
Journal:  Arch Gynecol Obstet       Date:  2017-11-24       Impact factor: 2.344

8.  Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.

Authors:  Umberto Leone Roberti Maggiore; Fabio Martinelli; Giulia Dondi; Giorgio Bogani; Valentina Chiappa; Maria Teresa Evangelista; Viola Liberale; Antonino Ditto; Simone Ferrero; Francesco Raspagliesi
Journal:  J Gynecol Oncol       Date:  2019-02-26       Impact factor: 4.401

9.  Ovarian metastasis in endometriod type endometrial cancer.

Authors:  Mitra Gilani Modaress; Fatemeh Cheraghi; Narges Zamani
Journal:  Int J Fertil Steril       Date:  2011-12-22

10.  Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.

Authors:  Yiying Wang; Yue Wang; Zhenbo Zhang; Ji-Young Park; Donghui Guo; Hong Liao; Xiaofang Yi; Yu Zheng; Donna Zhang; Setsuko K Chambers; Wenxin Zheng
Journal:  Oncotarget       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.